Med. praxi. 2013;10(2):50-53

Functional dyspepsia

prof.MUDr.Jiří Ehrmann, CSc.
II. interní klinika &ndash, gastro-enterologická a hepatologická LF UP a FN Olomouc

Educational narrative review apply to diagnostic procedures and treatment of the functional dyspepsia with respect to the Rome III

and traditional Czech classification. The special mention is to functional overlal syndromes, treatment of PPI and positivity of H. pylori in

patient with functional dyspesia. Therapy of functional dyspepsia have to be complex that is pharmacological and non-pharmacologial

inclusively psychological investigation. The accent is put on very well treatment effect of sulpirid.

Keywords: functional dyspepsia, classification, diagnosis, treatment

Published: February 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ehrmann J. Functional dyspepsia. Med. praxi. 2013;10(2):50-53.
Download citation

References

  1. Thomayer J. Pathologie a therapie nemocí vnitřních; Bursík&Kohout 1921, Praha 820-825.
  2. Mařatka Z. In.: Lukáš K, a spol. Funkční poruchy trávicího traktu. Grada: Praha 2003.
  3. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130, 1377-1390. Go to original source... Go to PubMed...
  4. Rome HP, Brannick TL. Psychiatric Aspects of Gastrointenstinal Function and Disease. Orientation and Mechanism of Functional Disorders. In Bockus HL. ed. Gastroenterology; WB. Saunders Copany Phyladelphia & London; Sec. Ed. 1965: 1079-1118.
  5. Manning AP, et al. BMJ 1978: 653-654.
  6. Torsolia A, et al. The WTR´s, the Delphic oracle and the Roma conclaves. Gastroenterol int 1991; 4: 44-45.
  7. Dalkey N, Brown B, Cochran S. The Delphi Method III. Use of self-rating to improve group estimates (RM-6115-PR). Santa Monica, California, Rand Corporation, June 1969.
  8. Drossman DA, et al. The Functional Gastrointestinal Disorders, Diagnosis, Pathology, and Treatment; Little Brown and Comp. Boston; 1994.
  9. Drosssman DA, Corazziari E, Talley NJ, el al. Rome II: A multinational consensus document on functional gastrointestinal disorders. Gut 1999; 80(Suppl II): 81. Go to original source... Go to PubMed...
  10. Tack J, Halley NJ, et al. Functional gastrointestinal disorders. Gastroenterology 2006; 130: 1466-1479. Go to original source... Go to PubMed...
  11. Seifert B. Přístup k pacientovi s dyspepsií v ordinaci praktického lékaře. In Gastroenterology 2012; 7-10; http://www. svl.cz.
  12. Corsetti M, Caenepeel P, Fischer B, et al. Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia. Am J Gastroenterol 2004; 99: 1152-1159. Go to original source... Go to PubMed...
  13. Cremonino F, Talley NJ. The overlap between functional dyspepsia and irritable bowel syndrome - a tale of one or two disorders? Aliment Pharmacol Ther 2004; 20(Suppl. 7): 40-49. Go to original source... Go to PubMed...
  14. Puera DA, Kovací TD, Metz CD, et al. Lansoprazole in the treatment of functional dyspepsie: two double-blind, randomized, placebo-controlled trials. Am J Med 2004; 116: 740-748. Go to original source... Go to PubMed...
  15. Rejchrt S, a spol. Delta values of the 13C-urea breath test in Helicobacter pylori positive persons with and without dyspepsia. Folia Gastroenterol Hepatol 2004; 2: 105-110.
  16. Bureš J, Kopáčová M, Rejchrt S. Pokles prevalence infekce Helicobacter pylori v České republice. Čas Lék čes 2008; 147: 255-257.
  17. Entnerová K, Kohout P. Funkční poruchy a alergie. In Lukáš K a spol. Praha: Grada 2003: 164-173.
  18. Honzák R. Pohled psychiatra na funkční poruchy trávícího traktu. In Lukáš K, a spol: Funkční poruchy trávícího traktu. Praha: Grada 2003: 174-192.
  19. Kratochvíl S. Gastrointestinální poruchy. In. Kratochvíl S. Klinická hypnóza. 2001; Praha: Grada 186-192.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.